Lv62
2154 积分 2023-10-27 加入
Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites
7天前
已完结
The Vasoconstrictor Action of Sumatriptan on Human Isolated Dura Mater
7天前
已完结
Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine
10天前
已完结
Rimegepant: First Approval
11天前
已完结
Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): A Potent Antagonist of the Human Calcitonin Gene-Related Peptide Receptor for Migraine with Rapid and Efficient Intranasal Exposure
12天前
已完结
Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success
12天前
已完结
Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): A potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery
12天前
已完结
Focus on zavegepant: the first intranasal third-generation gepant
13天前
已完结
Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay
13天前
已完结
Ubrogepant to treat migraine
13天前
已完结